Pfizer Inc. (SNSE:PFE)

Market Cap	136.59T
Revenue (ttm)	60.25T
Net Income (ttm)	9.43T
Shares Out	n/a
EPS (ttm)	1,656.68
PE Ratio	14.48
Forward PE	8.75
Dividend	1,640.06 (6,293.40%)
Ex-Dividend Date	Nov 7, 2025

Volume	n/a
Average Volume	n/a
Open	n/a
Previous Close	26.06
Day's Range	n/a
52-Week Range	22.18 - 27.75
Beta	0.71
RSI	0.00
Earnings Date	Feb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Santiago Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD